ArticlePDF Available

Experiential Cognitive Therapy in the Treatment of Panic Disorders with Agoraphobia: A Controlled Study

Authors:
  • Virtual Reality Medical Center

Abstract and Figures

The use of a multicomponent cognitive-behavioral treatment strategy for panic disorder with agoraphobia is actually one of the preferred therapeutic approaches for this disturbance. This method involves a mixture of cognitive and behavioral techniques that are intended to help patients identify and modify their dysfunctional anxiety-related thoughts, beliefs and behavior. The paper presents a new treatment protocol for Panic Disorder and Agoraphobia, named Experiential-Cognitive Therapy (ECT) that integrates the use of virtual reality (VR) in a multicomponent cognitive-behavioral treatment strategy. The VR software used for the trial is freely downloadable: www.cyberpsychology.info/try.htm. Moreover, the paper presents the result of a controlled study involving 12 consecutive patients aged 35-53. The selected subjects were randomly divided in three groups: ECT group, that experienced the Cognitive Behavioral Therapy-Virtual Reality assisted treatment (eight sessions), a CBT group that experienced the traditional Cognitive Behavioral approach (12 sessions) and a waiting list control group. The data showed that both CBT and ECT could significantly reduce the number of panic attacks, the level of depression and both state and trait anxiety. However, ECT procured these results using 33% fewer sessions than CBT. This datum suggests that ECT could be better than CBT in relation to the "cost of administration," justifying the added use of VR equipment in the treatment of panic disorders.
Content may be subject to copyright.
Experiential Cognitive Therapy in the Treatment of
Panic Disorders with Agoraphobia: A Controlled Study
F. VINCELLI, Ph.D.,
1,2
L. ANOLLI, Ph.D.,
2
S. BOUCHARD, Ph.D.,
3
B.K. WIEDERHOLD, Ph.D., M.B.A., BCIA,
4
V. ZURLONI, M.S.,
2
and G. RIVA, Ph.D.
1,2
ABSTRACT
The use of a multicomponent cognitive-behavioral treatment strategy for panic disorder with
agoraphobia is actually one of the preferred therapeutic approaches for this disturbance. This
method involves a mixture of cognitive and behavioral techniques that are intended to help
patients identify and modify their dysfunctional anxiety-related thoughts, beliefs and behav-
ior. The paper presents a new treatment protocol for Panic Disorder and Agoraphobia, named
Experiential-Cognitive Therapy (ECT) that integrates the use of virtual reality (VR) in a mul-
ticomponent cognitive-behavioral treatment strategy. The VR software used for the trial is
freely downloadable: www.cyberpsychology.info/try.htm. Moreover, the paper presents the
result of a controlled study involving 12 consecutive patients aged 35–53. The selected sub-
jects were randomly divided in three groups: ECT group, that experienced the Cognitive
Behavioral Therapy–Virtual Reality assisted treatment (eight sessions), a CBT group that ex-
perienced the traditional Cognitive Behavioral approach (12 sessions) and a waiting list con-
trol group. The data showed that both CBT and ECT could significantly reduce the number of
panic attacks, the level of depression and both state and trait anxiety. However, ECT procured
these results using 33% fewer sessions than CBT. This datum suggests that ECT could be bet-
ter than CBT in relation to the “cost of administration,” justifying the added use of VR equip-
ment in the treatment of panic disorders.
321
CYBERPSYCHOLOGY & BEHAVIOR
Volume 6, Number 3, 2003
© Mary Ann Liebert, Inc.
INTRODUCTION
W
ITHIN THE
Diagnostic and Statistical Manual of
Mental Disorders
framework,
1
the essential fea-
ture of panic disorder (PD) is the occurrence of panic
attacks. A panic attack is a sudden onset period of in-
tense fear or discomfort associated with a cluster of
physical and cognitive symptoms, which occur unex-
pectedly and recurrently, such as pervasive appre-
hension about panic attacks, persistent worry about
future attacks, worry about the perceived physical,
social or mental consequences of attacks, or major
changes in behavior in response to attacks. The disor-
der is often associated with circumscribed phobic
disorders such as specific phobias, social phobias,
and especially with agoraphobia.
2
Indeed, avoidance
of public places to reduce fear or panic becomes the
main cause of incapacity in patients, who, in more se-
rious cases, are confined to their homes patterns.
Clark, Salkovskis, Barlow, and other colleagues
have outlined the traditional Cognitive-Behavioral
Treatment (CBT) for PD with agoraphobia (PDA).
3–6
Evidence collected over the past 20 years has consis-
tently shown the effectiveness of a multicomponent
cognitive-behavioral strategy in the treatment of
panic disorder with agoraphobia.
1
Laboratorio Sperimentale di Psicologia, ATN-P Lab, Istituto Auxologico Italiano, Verbania, Italy.
2
Department of Psychology, Università Cattolica, Milan, Italy.
3
Department of Psychology, Universite du Quebec a Hull, Canada.
4
Virtual Reality Medical Center, San Diego, California.
The treatment package includes exposure to the
feared situation, interoceptive exposure, cognitive
restructuring, breathing retraining, and applied re-
laxation. On average, the duration of the protocol is
12–15 sessions.
7
The protocol involves a mixture of
cognitive and behavioral techniques, which are in-
tended to help patients identify and modify their
dysfunctional anxiety-related thoughts, beliefs and
behavior. Emphasis is placed on reversing the main-
taining factors identified in the cognitive and behav-
ioral patterns.
The paper presents a new treatment protocol for
PDA, named Experiential-Cognitive Therapy (ECT),
that integrates the use of virtual reality (VR) with the
traditional multicomponent CBT strategy.
8,9
Using
VR software, it is possible to re-create, with the sub-
ject undergoing treatment, a hierarchy of situations
corresponding to reality. Particularly, the feeling of
actual presence offered by the realistic reproduction
of cybernetic environments and by the involvement
of all the sensorimotor channels, enables the subject
undergoing treatment to live the virtual experience
in a more vivid and realistic manner than he could
through his own imagination.
10,11
The efficacy of the proposed approach is evalu-
ated in a controlled trial.
MATERIALS AND METHODS
The Experiential-Cognitive Therapy protocol
Francesco Vincelli and Giuseppe Riva at the Ap-
plied Technology for Neuro-Psychology Lab of Isti-
tuto Auxologico Italiano, Verbania, Italy, developed
the first version of the ECT protocol for PDA, in
cooperation with the Department of Psychology at
the Catholic University of Milan, Italy. The actual
version includes the efforts of researchers from the
Center for Advanced Multimedia Psychotherapy,
California School of Professional Psychology, San
Diego, from the Department of Psychology, Univer-
site du Quebec a Hull, Canada, and from the Seoul
Paik Hospital, Inje University, Seoul, Korea.
12,13
The clinical protocol.
The goal of ECT is to recon-
dition fear reactions, to modify misinterpretational
cognition related to panic symptoms and to reduce
anxiety symptoms through the integration of VR
experiences and traditional techniques of CBT. The
overall treatment is composed of eight sessions and
of different booster sessions for 6 months after the
therapy (Table 1).
The first goal of session 1 is to discuss with the
patient the etiologic model of PDA and to delineate
the program of ECT. The description is necessary to
obtain an active role of the patient in the therapy.
Then the patient is introduced to VR through the
use of a head-mounted display and a joystick. The
innovative principle of ECT is to integrate cogni-
tive and behavioral techniques with the experien-
tial possibilities offered by VR. Then the next step
of session 1 is to structure the graded exposure
5
procedure to virtual environments: the patient is
exposed to each of the four virtual environments,
with the minimum level of difficulty (e.g., small
number of subjects present in the environments,
ready access to the exits, plenty of room in the ele-
vator), and is asked to evaluate the experience on
subjective units of distress (SUDs) scale. In this
way, the therapist obtains a hierarchy of virtual en-
vironments, from the least anxiety provoking to the
most, which will be used along the treatment.
After a hierarchy of administration between the
environments has been established, the next step is
to establish a hierarchy of stimuli within each en-
vironment. In the ECT treatment program, the vir-
tual environments—an elevator, a supermarket, a
subway ride, and a large square—are designed to
reach this goal. In both the supermarket and under-
ground, the increase in difficulty may be obtained
by increasing the number of persons present in the
environment and by moving at a distance from the
exits of the environments. In the square, it is possi-
ble to increase the number of people present and to
approach narrower spaces that offer fewer ways
out. In the lift, it is possible to arrange for the pres-
ence of other people and to enlarge or restrict the
space inside the lift.
The following step is to show the patient the role
of avoidance as the main source of agoraphobic
and panic behaviors. The therapist underlines the
importance of regular exposure to feared situation
and structures with his patient a self-exposure
schedule.
In vivo
graded self-exposure as home-
work, initially with the co-therapist (when it is pos-
sible), is very important to empower the efficacy
of the therapy. This step can be more easily ap-
proached by graded exposure to virtual reality and
produces important advantages for the patient: re-
ducing the number of sessions, reducing depen-
dency on the therapist, and helping to maintain
therapeutic achievements.
Each session starts with the review of the home-
work, to verify the difficulties that have emerged
during self-exposure and to reinforce the patient for
the tasks that have been carried out. After the graded
exposure procedure and after session 2 focused on
cognitive assessment assisted through graded expo-
sure to virtual environments, session 3 is based on
322 VINCELLI ET AL.
cognitive restructuring.
5
In PD cognitive treatment
focuses upon correcting misappraisals of bodily sen-
sations as threatening. The cognitive strategies re-
duce attentional vigilance for symptoms of arousal,
level of chronic arousal, and anticipation of the recur-
rence of panic.
Cognitive treatment starts by reviewing with the
patient a recent panic attack and identifying the main
negative thoughts associated with the panic sensa-
tions. Once patient and therapist concord that the
panic attacks involve an interaction between bodily
sensations and negative thoughts about the sensa-
ECT AND PANIC DISORDERS WITH AGORAPHOBIA 323
TABLE 1. THE EXPERIENTIAL-COGNITIVE THERAPY PROTOCOL FOR
THE TREATMENT OF PANIC DISORDER WITH AGORAPHOBIA
Session 1
Description of the etiologic model of PDA according to cognitive behavioral approach
Connection between the model and a recent PDA of the patient
Introduction to Virtual Environments
Graded exposure to virtual environments and set a hierarchy of the virtual stimulus
Homework: diary of panic attacks
Session 2
Homework review
Cognitive assessment assisted through graded exposure to virtual environments
Introduction and scheduling of
in vivo
self-exposure
Homework: diary of panic attacks,
in vivo
self-exposure
Session 3
Homework Review
Cognitive restructuring assisted through graded exposure to virtual environments
Homework: diary of panic attacks,
in vivo
self-exposure
Session 4
Homework review
Graded exposure to virtual environments
Cognitive restructuring face to face
Homework: panic attacks diary,
in vivo
self-exposure
Session 5
Homework review
Interoceptive exposure
Interoceptive exposure assisted through graded exposure to virtual environments
Homework:
in vivo
interoceptive exposure, panic attacks diary
Session 6
Homework review
Interoceptive exposure assisted through graded exposure to virtual environments
Cognitive restructuring face to face
Homework:
in vivo
interoceptive exposure, diary of panic attacks
Session 7
Homework review
Interoceptive exposure assisted through graded exposure to virtual environments
Cognitive restructuring face to face
Homework:
in vivo
interoceptive exposure, diary of panic attacks
Session 8
Homework review
Cognitive restructuring and prevention relapse
Follow-up session schedule
Retest
Booster sessions
Follow-up after 1 month, 3 months, and 6 months
Review and reinforcement of patient’s tasks
Management and prevention of future relapse
tions, a variety of procedures is used to help patients
challenge their misinterpretations of the symptoms.
Many patients interpret the unexpected nature of
their panic attacks as an indication that they are
suffering from some physical abnormality. In these
cases, a psycho-education program presenting the
nature of anxiety can help, especially if it is tai-
lored to patient’s idiosyncratic concerns. One of the
prevalent errors in cognitions is overestimation.
The panickers are inclined to jump to negative con-
clusions and to treat negative events as probable
whereas they are unlikely to occur. Another type of
cognitive error is misinterpreting events as cata-
strophic. Decatastrophizing means to realize that
the occurrences are not ascatastrophic as stated,
which is achieved by contemplating how negative
events are managed versus how “bad” they are.
This is best done in a Socratic style,
5
so that clients
examine the content of their statements and reach
alternatives. The cognitive strategies are conducted
in conjunction with behavioral technique of graded
exposure in virtual reality. The schedule of session
4 is analogous to the one of session 3. The first part
is dedicated to graded exposure. The second part is
dedicated to the careful inquiry of cognitive distor-
tions and their modification.
The key feature of sessions 5–7 is interoceptive
exposure.
5
The theoretical basis for interoceptive
exposure is one of fear extinction, given the con-
ceptualization of panic attacks as conditioned”
alarm reactions to particular bodily cues. Since ac-
cording to the cognitive model panic disorder is
considered as a phobia of internal bodily cues,”
the purpose is to modify associations between spe-
cific bodily sensations and panic reactions. This
technique is also used during the exposure to the
virtual environments.
After cognitive restructuring, prevention relapse is
an important step of the last session, session 8. In this
session, the therapist schedules the self-exposure
homework and reinforces the patient for the tasks
that have been carried out and for the future tasks.
VR software.
For its use in ECT, Giuseppe Riva
designed the Virtual Environments for Panic Disor-
ders (VEPD) virtual reality system. VEPD is a four-
zone virtual environment developed using the
Superscape VRT 5.6 toolkit.
The four zones reproduce different potentially
fearful situationsan elevator, a supermarket, a
subway ride, and large square. In each zone, the
therapist, through a setup menu, defines the char-
acteristics of the anxiety-related experience. Specif-
ically, the therapist can define the length of the
virtual experience, its end and the number of vir-
tual subjects (from none to a crowd) to be included
in the zone.
Zone 1
: In this zone, an elevator in which the
subject has to enter, the subject becomes ac-
quainted with the proper control device, the
head mounted display and the recognition of
collisions.
Zone 2
: This zone shows a supermarket in which
the patient can go for shopping. The subject
can pick up objects and pay for them at the cash
register.
Zone 3
: This zone reproduces a subway ride. The
subject is located in the train that moves between
different stations.
Zone 4
: The last zone is a large square in which
are located a medieval church, different build-
ings, and a pub.
The VEPD software can be freely downloaded at
the web site www.cyberpsychology.info/try.htm. It
can be used on a standard PC with Pentium IV/
Celeron/Athlon 1.2 GHz or better, 64 MB of RAM
or better, graphic card with 32 MB of VRam or bet-
ter, using Windows 95/98/2000/NT/XP.
VR hardware.
The VR hardware includes the
following:
The head mounted display:
Glasstron PLM-A35 de-
veloped by Sony Inc., Japan. The Glasstron uses
LCD technology (two 0.7 inch active matrix color
LCD’s) displaying 180000 pixels (PLM-A35:
800H 2 225V) to each eye. Sony has designed its
Glasstron so that no optical adjustment at all is
needed, aside from tightening two ratchet knobs
to adjust for the size of the wearers head.
The motion gyroscopic tracker:
InterTrax 30 (serial
interface; azimuth, ±180 degrees; elevation, ±80
degrees; Refresh rate, 256 Hz; latency time, 38 6
2 msec)
A PC Pentium IV:
2 Ghz processor, 128 MB Ram
and a GeForce 4 Ti 200 graphic card
A joystick.
The controlled clinical trial
Sample.
Participants were recruited from people
who requested treatment at the Anxiety Units of
both the S. Carlo Hospital and the Niguarda Hospi-
tal in Milan, Italy. Eighteen female participants
were invited. To participate in the study, subjects
had to meet DSM-IV research criteria for anxiety
disorders for a minimum of 6 months determined
by independent clinicians on clinical interviews.
324 VINCELLI ET AL.
Individuals were excluded in the following
cases: if they were among people with psychotic or
bipolar disorders, or among those who show high
suicidal risks, or those who are medically ill (i.e.,
cardiac conduction disease, vestibular dysfunction)
and, finally, pregnant women. Twelve participants
met the inclusion criteria and took part in the study
(mean age, 43.83 66.68; range, 35–53 years).
The subjects who satisfied the entry criteria were
randomly assigned to one of the three conditions:
ECT group, CBT or waiting list control group. The
subjects in the ECT group were submitted to the
eight-session protocol described above. The subjects
in the CBT group were submitted to a standard
12-session protocol,
7
including classical CBT: cogni-
tive restructuring, Socratic style, interoceptive ex-
posure, and imaginative exposure to the feared
situations. The therapist involved in both CBT and
ECT (the first author of this paper) is a chartered
psychotherapist with a 4-year degree in CBT.
People on medication were not allowed to mod-
ify the prescribed dosage during the treatment. Be-
fore starting the trial, the nature of the treatment
was explained to the patients, and their written in-
formed consent was obtained.
Assessment.
Independent assessment clinicians
who were not involved in the direct clinical care of
any subject assessed subjects. They were M.A.-level
psychologists or Ph.D.-level psychotherapists. For
the clinical interview, they used a semi-structured
interview with the aim of identifying relevant DSM
IV diagnostic criteria in the subjects. All the sub-
jects were assessed at pretreatment and upon
completion of the clinical trial. The following psy-
chometric tests were administered at each assess-
ment point:
BDI-IIBeck Depression Inventory
14
: the BDD-
II consists of 21 items to assess the intensity of
depression in clinical and normal patients. Each
item is a list of four statements arranged in in-
creasing severity about a particular symptom of
depression.
STAIState-Trait Anxiety Inventory for
Adults
15,16
: The State-Trait Anxiety Inventory
for Adults (STAI-A) is comprised of 40 multi-
ple choice questions used for measuring anxi-
ety in adults. This scale differentiates between
the temporary condition of state anxiety” and
the more general and long-standing quality of
“trait anxiety.”
ACQAgoraphobic Cognitions Questionnaire
17
:
The Agoraphobic Cognitions Questionnaire con-
sists of 14 items, which may be scored as a total
scale or according to its two subscales: Loss of
Control and Physical Concerns. Each of the sub-
scales consists of seven items.
FQFear Questionnaire
18
: The Fear Question-
naire consists of 20 items surveying a wide range
of reasonably common sources of disturbed reac-
tions. Most items consist of phrases with 2–6
words evaluated on a five-point Likert scale: 0
(Not at all) to 4 (Very much).
During the assessment, the following were also
used:
Subjective measurements (self reports, diaries)
Subjective units of distress (SUDs) during expo-
sure to virtual environments. In particular, SUDs
were taken at baseline, after 10 min, and after
20 min.
Statistical analysis.
Given the limited size of the
sample, we decided to use three non-parametric
test: the Wilcoxon Mann-Whitney Test, the Wilcoxon
Signed Ranks Test, and the Kruskal-Wallis test.
19
The Wilcoxon Mann-Whitney Test is one of the
most powerful of the non-parametric tests for com-
paring two populations. It is used to test the null
hypothesis that two populations have identical dis-
tribution functions against the alternative hypothe-
sis that the two distribution functions differ only
with respect to location (median), if at all.
The Wilcoxon Signed Ranks Test is designed to
test a hypothesis about the location (median) of a
population distribution. It often involves the use of
matched pairs, for example, before and after data,
in which case it tests for a median difference of
zero. The Wilcoxon Signed Ranks test does not re-
quire the assumption that the population is nor-
mally distributed.
The Kruskal-Wallis test is a non-parametric test
used to compare three or more samples. It is used
to test the null hypothesis that all populations have
identical distribution functions against the alterna-
tive hypothesis that at least two of the samples dif-
fer only with respect to location (median), if at all.
RESULTS
Pre-treatment tests
No differences were found between the waiting
list condition and the treatment conditions at pre-
treatment in demographic and clinical variables:
age, duration of the fear, and level of perceived im-
pairment.
ECT AND PANIC DISORDERS WITH AGORAPHOBIA 325
Moreover, the Kruskal-Wallis tests showed no
significant discrepancies among the three groups
for the scales included in the assessment protocol.
Pre-post treatment tests
The Wilcoxon Signed Ranks test showed signif-
icant differences in the BDI-II, STAI and FQ scores
in the ECT and CBT group between pre- and post-
measurements (Table 2). In particular, both sam-
ple reported a general improvement in both the
level of depression and anxiety. Specifically, both
state and trait anxiety was lower after the treat-
ment. No differences were detected in the waiting
list group.
Then we used the Wilcoxon Mann-Whitney Test
to verify any significant difference between ECT
and CBT groups. The tests have not reported any
difference.
Clinically significant improvement
All the participants in the ECT and CBT group
achieved a clinically significant improvement using
strict criteria. In particular, the number of panic at-
tacks after the therapy in both cases decreased to
zero (Table 2).
None of the participants in the waiting list group
showed clinically significant improvement on the
post-test.
Drop-out
None of the participants refused treatment, and
none of them dropped out of the study.
Simulation sickness
None of the subjects who entered the ECT treat-
ment experienced simulation sickness during the
treatment.
CONCLUSION
One of the needed parameters in assessing the
effectiveness of therapies is the ratio existing be-
tween the “cost” of administration of the therapeu-
tic procedure and the resulting “benefits”
11
. By cost
it is meant the expenditure not only in terms of
money and time, but also in terms of emotional in-
volvement by the person to whom the therapy is
directed. The benefits regard the effectiveness of
the treatment, that is, the achievement of the target
set, in the shortest time possible. Exposure therapy
traditionally is carried out “in imagination” or
in
vivo
.” In the first case, the subject is trained to pro-
duce the anxiety-provoking stimuli through mental
images; in the second case, the subject actually
experiences these stimuli in semi-structured situa-
tions. Both methods present advantages and limita-
tions regarding the cost-benefit ratio. In the first
326 VINCELLI ET AL.
TABLE 2 SIGNIFICANT DIFFERENCES BETWEEN
THE THREE SAMPLES (PRE-POST ANALYSIS)
Waiting list CBT CBT-VR
Panic attacks
Pre 1.75 6 0.50 1.50 6 0.58 1.50 6 0.58
Post 1.75 6 0.50 0.00 6 0.00
a
0.00 6 0.00
a
BDI-II scores
Pre 23.00 6 0,16 24.00 6 0,82 23.25 6 2.75
Post 23.75 6 1.50 9.50 6 1.73
a
9.50 6 3.11
a
State anxiety scores
Pre 48.75 6 2.20 48.25 6 2.06 48.50 6 3.00
Post 49.00 6 3.16 38.00 6 2.83
a
38.75 6 6.08
a
Trait anxiety scores
Pre 47.75 6 1.71 48.25 6 2.63 48.50 6 3.37
Post 47.75 6 3.50 38.00 6 1.41
a
39.00 6 5.60
a
FQ scores
Pre 46.50 (5.00) 51.50 (7.55) 52.50 (13.80)
Post 48.00 (5.60) 41.50 (9.18)
a
38.00 (18.78)
a
a
The pre-post scores were significantly different (
p
< 0.05—Wilcoxon
Signed-Rank Test).
case, the prevalent difficulty is represented by
teaching the subject to produce the images that re-
gard experiences associated with anxiety: most fail-
ures linked to this therapy are those subjects who
present particular difficulties in visualizing scenes
of real life. The cost of the application, however, is
minimal, because the therapy is administered in
the physician’s office, thus avoiding situations that
might be embarrassing for the patient and safe-
guarding his privacy. In the second case, the diffi-
culty lies in structuring, in reality, experiences
regarding the hierarchically ordered anxiety-pro-
voking stimuli, so the cost in terms of time, money
and emotions is high. Then, the advantage of con-
tending with real contexts augments the likelihood
of effectiveness of the “
in vivo
” procedure.
In this paper, we proposed a new approach—
ECT—that integrates VR experiences with the tra-
ditional CBT. The feeling of actual presence offered
by the realistic reproduction of cybernetic environ-
ments and by the involvement of all the sensori-
motor channels enables the subject undergoing
treatment to live the virtual experience in a more
vivid and realistic manner than he could through
his own imagination. Moreover, VR constitutes a
highly flexible tool, which makes it possible to pro-
gram an enormous variety of procedures of inter-
vention on psychological distress. The possibility
of structuring a large amount of controlled stimuli
and, simultaneously, of monitoring the possible re-
sponses generated by the user of the program of-
fers a considerable increase in the likelihood of
therapeutic effectiveness, as compared to tradi-
tional procedures.
In the proposed method, we decided to integrate
the experience of the virtual environments with the
techniques included in the CBT approach because
they showed high levels of efficacy. Through vir-
tual environments we can gradually expose the
patient to feared situation: virtual reality consent
to re-create in our clinical office a real experiential
world. The patient faces the feared stimuli in a con-
text that is nearer to reality than imagination. Other
significant advantages are the supervised exposure
to agoraphobic situations and the possible boost to
the effectiveness of cognitive restructuring by prac-
ticing it in anxiety-inducing situations.
The result of this controlled studies showed that
ECT—like CBT—was able after the treatment to
significantly reduce the number of panic attacks,
the level of depression, and both state and trait
anxiety. Yet, ECT obtained these results using 33%
fewer sessions than CBT (eight vs. 12). This datum
suggests that ECT could be better than CBT in rela-
tion to the “cost of administration,” justifying the
added use of VR equipment in the treatment of
panic disorders.
Despite these findings we would like to address
some of the limitations of our study. First, the sam-
ple was carefully selected, but relatively small.
Studies with larger samples are needed. Second, we
did not include a follow-up assessment (e.g., 6
months later).
In conclusion, the present study demonstrated
that the exposure to the VR environments included
in ECT elicited strong psychological responses.
The anxiety and depression levels associated to
these responses decreased with exposure and with
repetition of exposures. In addition, ECT was
faster than CBT in reducing panic attacks as well
as anxiety and depression scores. We conclude
that VR—added to traditional CBT—offers a new
and promising approach for the treatment of PD
and presumably also for other phobias and anxiety
disorders.
ACKNOWLEDGMENTS
The present work was partially supported by the
Commission of the European Communities (CEC),
specifically by the IST program through the VEPSY
Updated (IST-2000–25323) research project (www.
cyberpsychology.info).
REFERENCES
1. APA. (1994). Diagnostic and statistical manual of mental
disorders, 4th ed. Washington, DC: American Psychi-
atric Association.
2. Goisman, R.M., Warshaw, M.G., Peterson, L.G., et al.
(1994). Panic, agoraphobia, and panic disorder with
agoraphobia: Data from a multicenter anxiety disor-
ders study. Journal of Nervous and Mental Diseases
182:7279.
3. Barlow, D.H. (1988). Anxiety and its disorders: the
nature and treatment of anxiety and panic. New York:
Guilford Press.
4. Barlow, D.H., & Craske, M.G. (1994). Mastery of your
anxiety and panic II. San Antonio, TX: Harcourt Brace
& Co.
5. Clark, D.M., Salkovskis, P., Gelder, M., et al. (1988).
Tests of a cognitive theory of panic. In: Hand, I., &
Wittchen, H., (eds.), Panic and phobias II. Berlin:
Springer-Verlag, pp. 78–95.
6. Clark, D.M., Salkovskis, P., Hackmann, A., et al.
(1994). A comparison of cognitive therapy, applied
relaxation, and imipramine in the treatment of panic
disorder. British Journal of Clinical Psychology 164:
756769.
ECT AND PANIC DISORDERS WITH AGORAPHOBIA 327
7. Rapee, R.M., & Barlow, D.H. (1991). The cognitive-
behavioral treatment of panic attacks and agora-
phobic avoidance. In: Walker, J.R., Norton, G.R.,
Ross, C.A., (eds.), Panic disorders and agoraphobia. Pa-
cific Grove: Brooks/Cole Publishing Company, pp.
10349.
8. Vincelli, F., Choi, Y.H., Molinari, E., et al. (2000). Expe-
riential cognitive therapy for the treatment of panic
disorder with agoraphobia: definition of a clinical
protocol. CyberPsychology & Behavior 3:375–385.
9. Vincelli, F., Choi, Y.H., Molinari, E., et al. (2001). A
VR-based multicomponent treatment for panic dis-
orders with agoraphobia. Studies in Health Technology
and Informatics 81:544–550.
10. Riva, G., Molinari, E., Vincelli, F. (2002). Interaction
and presence in the clinical relationship: virtual real-
ity (VR) as communicative medium between patient
and therapist. IEEE Transactions on Information Tech-
nology in Biomedicine 6:198205.
11. Vincelli, F. (1999). From imagination to virtual real-
ity: the future of clinical psychology. CyberPsychology
& Behavior 2:241248.
12. Vincelli, F., Choi, Y.H., Molinari, E., et al. (2000). Expe-
riential cognitive therapy for the treatment of panic
disorders with agoraphobia: definition of a clinical
protocol. CyberPsychology & Behavior 3:375–386.
13. Vincelli, F., Riva, G. (2002). Virtual reality: a new tool
for panic disorder therapy. Expert Review of Neuro-
therapeutics 2:377–383.
14. Beck, A.T., Ward, C.H., Mendelson, M., et al. (1961).
An inventory for measuring depression. Archives of
General Psychiatry. 4:561–571.
15. Spielberger, C.D., Gorsuch, R.L., Lushene, R.E. (1970).
The State-Trait Anxiety Inventory: test manual for form
X. Palo Alto, CA: Consulting Psychologist Press.
16. Spielberger, C.D., Gorsuch, R.L., Lushene, R., et al.
(1983). Manual for the State-Trait Anxiety Inventor.
Palo Alto, CA: Consulting Psychology Press.
17. Chambless, D.L., Caputo, G.S., Bright, P., et al. (1984).
Assessment of fear of fear on agoraphobics. The Bod-
ily Sensation Questionnaire and the Agoraphobic
Cognitions Questionnaire. Journal of Consulting &
Clinical Psychology 52:1090–1097.
18. Marks, I.M., & Mathews, A.M. (1979). Brief standard
self-rating for phobic patients. Behavior Research and
Therapy 17:263267
19. Randles, R.H., & Wolfe, D.A. (1979). Introduction to
the theory of nonparametric statistics. London: Wiley.
Address reprint requests to:
Francesco Vincelli, Ph.D.
Laboratorio Sperimentale di Ricerche Psicologiche
Istituto Auxologico Italian
Casella Postale 1
28900, Verbania, Italy
E-mail:
fvincelli@hotmail.com
328 VINCELLI ET AL.
... Virtual Reality (VR) and Augmented Reality (AR) are emerging technologies that have the potential to enhance existing means of diagnosing and treating mental health disorders [1][2][3][4][5][6]. VR is an immersion experience that shuts out the physical world (e.g. using a 360° head-mounted display [7]. ...
... Using AR/VR, a patient's reality can be explored, expanded, and challenged. Visual, auditory, haptic, somatosensory, and olfactory stimuli can be applied to enhance general wellness, encourage learning, provide entertainment value, and target aberrant behaviors or cognitive patterns [2,5]. The concept of VR was first formulated in the 1960's and the first commercial tools appeared on the market in the 1980's [9]. ...
Article
Full-text available
Objective Immersive virtual reality (VR) and augmented reality (AR) have the potential to improve the treatment and diagnosis of individuals experiencing psychosis. Although commonly used in creative industries, emerging evidence reveals that VR is a valuable tool to potentially improve clinical outcomes, including medication adherence, motivation, and rehabilitation. However, the efficacy and future directions of this novel intervention require further study. The aim of this review is to search for evidence of efficacy in enhancing existing psychosis treatment and diagnosis with AR/VR. Methods 2069 studies involving AR/VR as a diagnostic and treatment option were reviewed via PRISMA guidelines in five databases: PubMed, PsychInfo, Embase, and CINAHL. Results Of the initial 2069 articles, 23 original articles were eligible for inclusion. One study applied VR to the diagnosis of schizophrenia. Most studies demonstrated that the addition of VR therapies and rehabilitation methods to treatment-as-usual (medication, psychotherapy, social skills training) was more effective than traditional methods alone in treating psychosis disorders. Studies also support the feasibility, safety, and acceptability of VR to patients. No articles using AR as a diagnostic or treatment option were found. Conclusions VR is efficacious in diagnosing and treating individuals experiencing psychosis and is a valuable augmentation of evidence-based treatments.
... A meta-analysis by Eichenberg and Wolters (2012) showed, that exposure therapy in virtual reality (VRET) is effective for the disorders of specific phobia and social anxiety disorder. A reduction in subjectively reported symptoms (e. g. fear, avoidance behavior) and arousal of patients with PD and agoraphobia could be observed after VRET (Botella et al., 2007;Malbos et al., 2013;Pelissolo et al., 2012;Vincelli et al., 2003). In a systematic review by Freitas et al. (2021) regarding the effects of VRET compared with in vivo exposure in anxiety disorders, the authors describe comparable effects of in vivo exposure and VRET in different anxiety disorders. ...
Preprint
In vivo exposure is a highly effective but rarely implemented treatment for agoraphobia. Most of the patients receive medication or cognitive therapy without exposure because of a high expenditure of money and time for in vivo exposure. Exposure in virtual reality (VR) is easier to implement but the effectiveness of stimulating fear compared to in vivo exposure is still questionable. Therefore, in this study, the effects of in vivo and VR exposure on subjective symptom burden and heart rate variability (HRV) were assessed. 30 healthy individuals with fears in narrow rooms went through in vivo and VR exposure in a randomized order while HRV parameters (RMSSD, HF) and subjective symptom burden was assessed. Linear mixed models were calculated. The effect of condition (VR vs. in vivo), scenario (several narrow rooms) and slot (first 30 seconds, peak, last 30 seconds) on RMSSD and HF was assessed. A random effect for participants (random-intercept term) to allow the intercept to vary across participants was included. Regarding RMSSD and HF, participants showed significantly higher levels during in vivo exposure compared to exposure in VR (RMSSD: p = .005; HF: p < .001), reflecting a stronger activation of the parasympathetic nervous system during in vivo exposure or presumably higher stress levels during VR exposure. This study highlights the necessity of assessing subjective and objective parameters allowing the evaluation of the effectiveness of fear stimulation by exposure approaches. The effectiveness of VR exposure for agoraphobic patients’ needs to be assessed in future studies.
... Panic Disorder. Studies on PD with or without agoraphobia made up 10% of the included studies (Botella et al., 2000(Botella et al., , 2007Castro et al., 2014;Choi et al., 2005 Quero et al., 2014;Vincelli et al., 2003;Znaidi et al., 2006). On average, 65% of participants in these studies were female, and 35% were male. ...
Article
Background: & Objectives: Virtual Reality (VR) refers to an artificial, immersive three-dimensional environment with interactive sensory stimuli. VR is typically incorporated into the psychotherapeutic process as a means of providing exposure therapy. The objectives of this scoping review were to synthesize the most up-to-date evidence on the outcomes, acceptability, and side effects of VR interventions for treating anxiety disorders in adults. Methods: This scoping review is grounded in the methodological framework of Arksey and O'Malley (2005). The databases searched were PubMed, EMBASE, Web of Science, PsycINFO, and ProQuest Dissertations and Theses. Results: The search process identified 112 unique citations. 52 (46%) of the eligible articles examined participants with specific phobias, 25 (22%) with PTSD, 21 (19%) with social anxiety disorder, 12 (10%) with panic disorder with or without agoraphobia, and 3 (3%) with generalized anxiety disorder. VR interventions often led to statistically significant and meaningful reductions in symptoms for people with anxiety disorders. Additionally, they were acceptable to clients and associated with minimal side effects for all types of anxiety disorders, except for Combat-Related PTSD in Vietnam veterans. Limitations: Limitations included the fact that the studies in this review were of varying quality, and that articles in languages other than English and French were excluded. Conclusion: VR interventions appeared to be a viable alternative to conventional exposure therapy. Future research should include more male participants and have a stronger emphasis on acceptability and side effects. Increased traction for VR interventions for generalized anxiety disorder and panic disorder is also important.
... H. Spiegel (1970) was the first who used hypnosis for smokers who wanted to quit the habit. He used an approach based on one session of hypnosis, during which he offered patients the opportunity to place the problem in a new perspective. ...
... VR systems have proven to be useful clinically for treating a variety of phobias and psychological disorders (Riva et al., 2019). Some of these include social phobias (Klinger et al., 2005), panic and anxiety disorders (such as acrophobia, fear of flying/driving, etc.) (Vincelli et al., 2003;Botella et al., 2004), as well as obsessive-compulsive or post-traumatic stress disorders (Gregg and Tarrier, 2007;Fox et al., 2009;Slater, 2009;Meyerbröker and Emmelkamp, 2010), and other addictive behaviors (Lee, 2004). VR systems offer a highly flexible method for creating and manipulating scenarios that might be dangerous to simulate in real life (Bailenson et al., 2004). ...
Article
Full-text available
This article looks through a critical media lens at mediated effects and ethical concerns of virtual reality (VR) applications that explore personal and social issues through embodiment and storytelling. In recent years, the press, immersive media practitioners and researchers have promoted the potential of virtual reality storytelling to foster empathy. This research offers an interdisciplinary narrative review, with an evidence-based approach to challenge the assumptions that VR films elicit empathy in the participant—what I refer to as the VR-empathy model. A review of literature from the fields of psychology, computer science, embodiment, medicine, and virtual reality was carried out to question and counter these claims through case studies of both fiction and non-fiction VR experiences. The results reveal that there is little empirical evidence of a correlation between VR exposure and an increase in empathy that motivates pro-social behavior, and a lack of research covering VR films exposure eliciting empathy. Furthermore, the results show an alarming lack of research into the long-term effects of VR films and other VR immersive experiences. This contribution aims to understand and demystify the current “empathy machine” rhetoric and calls for more rigorous, scientific research that can authenticate future claims and systemize ethical best practices.
... Marchand et al. zeigten, dass sowohl Kurzzeittherapie, Langzeittherapie und Gruppentherapie stabile Effekte gegenüber einer Wartegruppe erzielen (Marchand, Roberge, Primiano, & Germain, 2009). Vincelli konnte eine signifikante Verbesserung mit verhaltenstherapeutischen Techniken im virtuellen Raum nach 20 Sitzungen (davon10 Stunden kognitive Verhaltenstherapie mit Therapeut) belegen (Vincelli et al., 2003) . Bei Kenardy et al. zeigten sich 12 Sitzungen und 6 Sitzungen CBT einer Warteliste überlegen. ...
... Jang et al. (2000) conducted an open, uncontrolled study to determine the benefits of virtual reality therapy in people with panic disorder with agoraphobia. Panic disorder with agoraphobia can be treated by the Experiential-Cognitive Therapy developed by Vincelli et al. (2003a) (Table 6). ...
Article
Full-text available
Extended reality (XR) solutions are quietly maturing, and their novel use cases are already being investigated, particularly in the healthcare industry. By 2022, the extended reality market is anticipated to be worth $209 billion. Certain diseases, such as Alzheimer's, Schizophrenia, Stroke rehabilitation stimulating specific areas of the patient's brain, healing brain injuries, surgeon training, realistic 3D visualization, touch-free interfaces, and teaching social skills to children with autism, have shown promising results with XR-assisted treatments. Similar effects have been used in video game therapies like Akili Interactive's EndeavorRx, which has previously been approved by the Food and Drug Administration (FDA) as a treatment regimen for children with attention deficit hyperactivity disorder (ADHD). However, while these improvements have received positive feedback, the field of XR-assisted patient treatment is in its infancy. The growth of XR in the healthcare sphere has the potential to transform the delivery of medical services. Imagine an elderly patient in a remote setting having a consultation with a world-renowned expert without ever having to leave their house. Rather than operating on cadavers in a medical facility, a surgical resident does surgery in a virtual setting at home. On the first try, a nurse uses a vein finder to implant an IV. Through cognitive treatment in a virtual world, a war veteran recovers from post-traumatic stress disorder (PTSD). The paper discusses the potential impact of XR in transforming the healthcare industry, as well as its use cases, challenges, XR tools and techniques for intelligent health care, recent developments of XR in intelligent healthcare services, and the potential benefits and future aspects of XR techniques in the medical domain.
Chapter
Virtual Reality (VR) is a growing field in psychological research and therapy. While there is strong evidence for the efficacy of exposure therapy in VR (VRET) to treat anxiety disorders, new opportunities for using VR to treat mental health disorders are emerging. In this chapter, we first describe the value of VRET for the treatment of several anxiety disorders. Next, we introduce some recent developments in research using VR investigating schizophrenia, neurodevelopmental disorders, and eating disorders. This includes therapeutic strategies beyond VRET, including avatar-based therapies or those combining VR with biofeedback approaches. Although VR offers many convincing advantages, contraindications in treatment must be considered when implementing VR-supported therapy in clinical practice. Finally, we provide an outlook for future research, highlighting the integration of augmented reality and automation processes in VR environments to create more efficient and tailored therapeutic tools. Further, future treatments will benefit from the gamification approach, which integrates elements of computer games and narratives that promote patients’ motivation and enables methods to reduce drop-outs during psychological therapy.KeywordsBiofeedbackExposure therapyMental healthVirtual reality
Chapter
Full-text available
Panic attacks are one of the most distressing of all forms of anxiety. The sudden onset of attacks and the intense bodily sensations which accompany them often lead patients to think they are about to die, go crazy, or suffer some other catastrophe. The fact that some attacks also appear to occur without warning is additionally alarming to patients and was initially interpreted by research workers as an indication that the central disorder in panic is a neurochemical disturbance. This point of view received further support from work on the pharmacological induction and treatment of panic. However, a number of investigators (Barlow, in press; Beck et al. 1985; Clark 1979, 1986; Griez and van den Hout 1984; Margraf et al. 1986; Rapee 1987, Seligman 1988) have recently proposed psychological theories which can also account for the main features of panic. In the present paper we provide a brief overview of one of the these theories — the cognitive theory described by Clark (1986) — and describe a series of experiments testing central predictions derived from this theory. Readers who would like a more detailed exposition of the theory are referred to Clark (1986, 1988) and Salkovskis (1988).
Article
Full-text available
Recent studies have shown that cognitive therapy is an effective treatment for panic disorder. However, little is known about how cognitive therapy compares with other psychological and pharmacological treatments. To investigate this question 64 panic disorder patients were initially assigned to cognitive therapy, applied relaxation, imipramine (mean 233 mg/day), or a 3-month wait followed by allocation to treatment. During treatment patients had up to 12 sessions in the first 3 months and up to three booster sessions in the next 3 months. Imipramine was gradually withdrawn after 6 months. Each treatment included self-exposure homework assignments. Cognitive therapy and applied relaxation sessions lasted one hour. Imipramine sessions lasted 25 minutes. Assessments were before treatment/wait and at 3, 6, and 15 months. Comparisons with waiting-list showed all three treatments were effective. Comparisons between treatments showed that at 3 months cognitive therapy was superior to both applied relaxation and imipramine on most measures. At 6 months cognitive therapy did not differ from imipramine and both were superior to applied relaxation on several measures. Between 6 and 15 months a number of imipramine patients relapsed. At 15 months cognitive therapy was again superior to both applied relaxation and imipramine but on fewer measures than at 3 months. Cognitive measures taken at the end of treatment were significant predictors of outcome at follow-up.
Article
The use of a multicomponent cognitive-behavioral treatment strategy for panic disorder with agoraphobia is actually one of the preferred therapeutical approach for this disturbance. This method involves a mixture of cognitive and behavioral techniques which are intended to help patients identify and modify their dysfunctional anxiety-related thoughts, beliefs and behavior. Emphasis is placed on reversing the maintaining factors identified in the cognitive and behavioral patterns. The treatment protocol includes exposure to the feared situation, interoceptive exposure and cognitive restructuring. The paper presents a treatment protocol for panic disorder and agoraphobia, named experiential-cognitive therapy, that integrates the use of virtual reality in a multicomponent cognitive-behavioral treatment strategy. The goal of experiential-cognitive therapy is to decondition fear reactions, to modify misinterpretational cognition related to panic symptoms and to reduce anxiety symptoms.
Article
The possible role of virtual reality (VR) in clinical psychology derives prevalently from the central role occupied by the imagination and by memory in psychotherapy. These two elements, which are fundamental in the life of everyone, present absolute and relative limits to individual potential. Thanks to virtual experiences, it is possible to transcend these limits. The re-created world may be more vivid and real at times than the one that most subjects are able to describe through their own imagination and through their own memory. This article focuses on imaginative techniques to find new ways of applications in therapy. In particular, the way VR can be used to improve the efficacy of current techniques is explored. VR produces a change with respect to the traditional relationship between client and therapist. The new configuration of this relationship is based on the awareness of being more skilled in the difficult operations of recovery of past experiences through the memory and of foreseeing future experiences through the imagination. At the same time, subjects undergoing treatment perceive the advantage of being able to recreate and use a real experiential world within the confines of their therapists's clinical offices.
Article
A one-page self-rating form is described to monitor change in phobic patients. It is derived from earlier versions used in 1000 phobic club members and 300 phobic patients. The form yields four scores: main phobia, global phobia, total phobia and anxiety-depression. The total phobia score is composed of agoraphobia, social and blood-injury subgroups. The form is short, reliable and valid. Adoption of this standard form for research in clinical populations would facilitate comparison of results across centres and studies.
Article
Describes the development of the Agoraphobic Cognitions Questionnaire and the Body Sensations Questionnaire, companion measures for assessing aspects of fear of fear (panic attacks) in agoraphobics. The instruments were administered to 175 agoraphobics (mean age 37.64 yrs) and 43 controls (mean age 36.13 yrs) who were similar in sex and marital status to experimental Ss. Results show that the instruments were reliable and fared well on tests of discriminant and construct validity. It is concluded that these questionnaires are useful, inexpensive, and easily scored measures for clinical and research applications and fill a need for valid assessment of this dimension of agoraphobia. (22 ref) (PsycINFO Database Record (c) 2012 APA, all rights reserved)